Page last updated: 2024-11-02

perhexiline and Ventricular Fibrillation

perhexiline has been researched along with Ventricular Fibrillation in 1 studies

Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research Excerpts

ExcerptRelevanceReference
"The effectiveness of perhexiline maleate in the suppression of ventricular ectopic activity has been studied in 10 patients after myocardial infarction."5.04Long-term effect of perhexiline maleate on ventricular ectopic activity. ( Myburgh, DP, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myburgh, DP1

Trials

1 trial available for perhexiline and Ventricular Fibrillation

ArticleYear
Long-term effect of perhexiline maleate on ventricular ectopic activity.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1978, Apr-01, Volume: 53, Issue:13

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Male; Middle Aged; M

1978